0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Anti-inflammatory Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-6H14514
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti inflammatory Therapy Market Research Report 2023
BUY CHAPTERS

Anti-inflammatory Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-6H14514
Report
October 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-inflammatory Therapy - Market Size

The global market for Anti-inflammatory Therapy was estimated to be worth US$ 110540 million in 2023 and is forecast to a readjusted size of US$ 168750 million by 2030 with a CAGR of 6.1% during the forecast period 2024-2030

Anti-inflammatory Therapy - Market

Anti-inflammatory Therapy - Market

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Anti-inflammatory Therapy by region & country, by Type, and by Application.
The Anti-inflammatory Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapy.
Market Segmentation

Scope of Anti-inflammatory Therapy - Market Report

Report Metric Details
Report Name Anti-inflammatory Therapy - Market
Forecasted market size in 2030 US$ 168750 million
CAGR 6.1%
Forecasted years 2024 - 2030
Segment by Type:
  • Corticosteroids
  • Anti-inflammatory Biologics
  • Non-Steroidal Anti-inflammatory Drugs
  • Others
Segment by Application
  • Respiratory Diseases
  • Arthritis
  • Gastroenterology
  • Dermatology
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Anti-inflammatory Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Anti-inflammatory Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Anti-inflammatory Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Anti-inflammatory Therapy - Market size in 2030?

Ans: The Anti-inflammatory Therapy - Market size in 2030 will be US$ 168750 million.

Who are the main players in the Anti-inflammatory Therapy - Market report?

Ans: The main players in the Anti-inflammatory Therapy - Market are AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA

What are the Application segmentation covered in the Anti-inflammatory Therapy - Market report?

Ans: The Applications covered in the Anti-inflammatory Therapy - Market report are Respiratory Diseases, Arthritis, Gastroenterology, Dermatology, Others

What are the Type segmentation covered in the Anti-inflammatory Therapy - Market report?

Ans: The Types covered in the Anti-inflammatory Therapy - Market report are Corticosteroids, Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs, Others

1 Market Overview
1.1 Anti-inflammatory Therapy Product Introduction
1.2 Global Anti-inflammatory Therapy Market Size Forecast
1.3 Anti-inflammatory Therapy Market Trends & Drivers
1.3.1 Anti-inflammatory Therapy Industry Trends
1.3.2 Anti-inflammatory Therapy Market Drivers & Opportunity
1.3.3 Anti-inflammatory Therapy Market Challenges
1.3.4 Anti-inflammatory Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anti-inflammatory Therapy Players Revenue Ranking (2023)
2.2 Global Anti-inflammatory Therapy Revenue by Company (2019-2024)
2.3 Key Companies Anti-inflammatory Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Anti-inflammatory Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Anti-inflammatory Therapy
2.6 Anti-inflammatory Therapy Market Competitive Analysis
2.6.1 Anti-inflammatory Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Anti-inflammatory Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Corticosteroids
3.1.2 Anti-inflammatory Biologics
3.1.3 Non-Steroidal Anti-inflammatory Drugs
3.1.4 Others
3.2 Global Anti-inflammatory Therapy Sales Value by Type
3.2.1 Global Anti-inflammatory Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Anti-inflammatory Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Anti-inflammatory Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Respiratory Diseases
4.1.2 Arthritis
4.1.3 Gastroenterology
4.1.4 Dermatology
4.1.5 Others
4.2 Global Anti-inflammatory Therapy Sales Value by Application
4.2.1 Global Anti-inflammatory Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Anti-inflammatory Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Anti-inflammatory Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Anti-inflammatory Therapy Sales Value by Region
5.1.1 Global Anti-inflammatory Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Anti-inflammatory Therapy Sales Value by Region (2019-2024)
5.1.3 Global Anti-inflammatory Therapy Sales Value by Region (2025-2030)
5.1.4 Global Anti-inflammatory Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Anti-inflammatory Therapy Sales Value, 2019-2030
5.2.2 North America Anti-inflammatory Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Anti-inflammatory Therapy Sales Value, 2019-2030
5.3.2 Europe Anti-inflammatory Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Anti-inflammatory Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific Anti-inflammatory Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Anti-inflammatory Therapy Sales Value, 2019-2030
5.5.2 South America Anti-inflammatory Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Anti-inflammatory Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa Anti-inflammatory Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anti-inflammatory Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Anti-inflammatory Therapy Sales Value
6.3 United States
6.3.1 United States Anti-inflammatory Therapy Sales Value, 2019-2030
6.3.2 United States Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Anti-inflammatory Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Anti-inflammatory Therapy Sales Value, 2019-2030
6.4.2 Europe Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Anti-inflammatory Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Anti-inflammatory Therapy Sales Value, 2019-2030
6.5.2 China Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Anti-inflammatory Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Anti-inflammatory Therapy Sales Value, 2019-2030
6.6.2 Japan Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Anti-inflammatory Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Anti-inflammatory Therapy Sales Value, 2019-2030
6.7.2 South Korea Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Anti-inflammatory Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Anti-inflammatory Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Anti-inflammatory Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Anti-inflammatory Therapy Sales Value, 2019-2030
6.9.2 India Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Anti-inflammatory Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Profile
7.1.2 AbbVie Main Business
7.1.3 AbbVie Anti-inflammatory Therapy Products, Services and Solutions
7.1.4 AbbVie Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 AbbVie Recent Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Profile
7.2.2 Johnson & Johnson Main Business
7.2.3 Johnson & Johnson Anti-inflammatory Therapy Products, Services and Solutions
7.2.4 Johnson & Johnson Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Johnson & Johnson Recent Developments
7.3 Amgen Inc
7.3.1 Amgen Inc Profile
7.3.2 Amgen Inc Main Business
7.3.3 Amgen Inc Anti-inflammatory Therapy Products, Services and Solutions
7.3.4 Amgen Inc Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 AstraZeneca PLC Recent Developments
7.4 AstraZeneca PLC
7.4.1 AstraZeneca PLC Profile
7.4.2 AstraZeneca PLC Main Business
7.4.3 AstraZeneca PLC Anti-inflammatory Therapy Products, Services and Solutions
7.4.4 AstraZeneca PLC Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 AstraZeneca PLC Recent Developments
7.5 Pfizer, Inc
7.5.1 Pfizer, Inc Profile
7.5.2 Pfizer, Inc Main Business
7.5.3 Pfizer, Inc Anti-inflammatory Therapy Products, Services and Solutions
7.5.4 Pfizer, Inc Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 Pfizer, Inc Recent Developments
7.6 Novartis
7.6.1 Novartis Profile
7.6.2 Novartis Main Business
7.6.3 Novartis Anti-inflammatory Therapy Products, Services and Solutions
7.6.4 Novartis Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 Novartis Recent Developments
7.7 Roche
7.7.1 Roche Profile
7.7.2 Roche Main Business
7.7.3 Roche Anti-inflammatory Therapy Products, Services and Solutions
7.7.4 Roche Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 Roche Recent Developments
7.8 Merck
7.8.1 Merck Profile
7.8.2 Merck Main Business
7.8.3 Merck Anti-inflammatory Therapy Products, Services and Solutions
7.8.4 Merck Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 Merck Recent Developments
7.9 Sanofi
7.9.1 Sanofi Profile
7.9.2 Sanofi Main Business
7.9.3 Sanofi Anti-inflammatory Therapy Products, Services and Solutions
7.9.4 Sanofi Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 Sanofi Recent Developments
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Profile
7.10.2 GlaxoSmithKline Main Business
7.10.3 GlaxoSmithKline Anti-inflammatory Therapy Products, Services and Solutions
7.10.4 GlaxoSmithKline Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 GlaxoSmithKline Recent Developments
7.11 Sun Pharmaceutical Industries Ltd
7.11.1 Sun Pharmaceutical Industries Ltd Profile
7.11.2 Sun Pharmaceutical Industries Ltd Main Business
7.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Products, Services and Solutions
7.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
7.12 TEVA
7.12.1 TEVA Profile
7.12.2 TEVA Main Business
7.12.3 TEVA Anti-inflammatory Therapy Products, Services and Solutions
7.12.4 TEVA Anti-inflammatory Therapy Revenue (US$ Million) & (2019-2024)
7.12.5 TEVA Recent Developments
8 Industry Chain Analysis
8.1 Anti-inflammatory Therapy Industrial Chain
8.2 Anti-inflammatory Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anti-inflammatory Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Anti-inflammatory Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Anti-inflammatory Therapy Market Trends
    Table 2. Anti-inflammatory Therapy Market Drivers & Opportunity
    Table 3. Anti-inflammatory Therapy Market Challenges
    Table 4. Anti-inflammatory Therapy Market Restraints
    Table 5. Global Anti-inflammatory Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Anti-inflammatory Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Anti-inflammatory Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Anti-inflammatory Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Anti-inflammatory Therapy
    Table 10. Global Anti-inflammatory Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Anti-inflammatory Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Anti-inflammatory Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Anti-inflammatory Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Anti-inflammatory Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Anti-inflammatory Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Anti-inflammatory Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Anti-inflammatory Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Anti-inflammatory Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Anti-inflammatory Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Anti-inflammatory Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Anti-inflammatory Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Anti-inflammatory Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Anti-inflammatory Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Anti-inflammatory Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Anti-inflammatory Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Anti-inflammatory Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Anti-inflammatory Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Anti-inflammatory Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. AbbVie Basic Information List
    Table 32. AbbVie Description and Business Overview
    Table 33. AbbVie Anti-inflammatory Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Anti-inflammatory Therapy Business of AbbVie (2019-2024)
    Table 35. AbbVie Recent Developments
    Table 36. Johnson & Johnson Basic Information List
    Table 37. Johnson & Johnson Description and Business Overview
    Table 38. Johnson & Johnson Anti-inflammatory Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Anti-inflammatory Therapy Business of Johnson & Johnson (2019-2024)
    Table 40. Johnson & Johnson Recent Developments
    Table 41. Amgen Inc Basic Information List
    Table 42. Amgen Inc Description and Business Overview
    Table 43. Amgen Inc Anti-inflammatory Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Anti-inflammatory Therapy Business of Amgen Inc (2019-2024)
    Table 45. Amgen Inc Recent Developments
    Table 46. AstraZeneca PLC Basic Information List
    Table 47. AstraZeneca PLC Description and Business Overview
    Table 48. AstraZeneca PLC Anti-inflammatory Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Anti-inflammatory Therapy Business of AstraZeneca PLC (2019-2024)
    Table 50. AstraZeneca PLC Recent Developments
    Table 51. Pfizer, Inc Basic Information List
    Table 52. Pfizer, Inc Description and Business Overview
    Table 53. Pfizer, Inc Anti-inflammatory Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Anti-inflammatory Therapy Business of Pfizer, Inc (2019-2024)
    Table 55. Pfizer, Inc Recent Developments
    Table 56. Novartis Basic Information List
    Table 57. Novartis Description and Business Overview
    Table 58. Novartis Anti-inflammatory Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Anti-inflammatory Therapy Business of Novartis (2019-2024)
    Table 60. Novartis Recent Developments
    Table 61. Roche Basic Information List
    Table 62. Roche Description and Business Overview
    Table 63. Roche Anti-inflammatory Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Anti-inflammatory Therapy Business of Roche (2019-2024)
    Table 65. Roche Recent Developments
    Table 66. Merck Basic Information List
    Table 67. Merck Description and Business Overview
    Table 68. Merck Anti-inflammatory Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Anti-inflammatory Therapy Business of Merck (2019-2024)
    Table 70. Merck Recent Developments
    Table 71. Sanofi Basic Information List
    Table 72. Sanofi Description and Business Overview
    Table 73. Sanofi Anti-inflammatory Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Anti-inflammatory Therapy Business of Sanofi (2019-2024)
    Table 75. Sanofi Recent Developments
    Table 76. GlaxoSmithKline Basic Information List
    Table 77. GlaxoSmithKline Description and Business Overview
    Table 78. GlaxoSmithKline Anti-inflammatory Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Anti-inflammatory Therapy Business of GlaxoSmithKline (2019-2024)
    Table 80. GlaxoSmithKline Recent Developments
    Table 81. Sun Pharmaceutical Industries Ltd Basic Information List
    Table 82. Sun Pharmaceutical Industries Ltd Description and Business Overview
    Table 83. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Anti-inflammatory Therapy Business of Sun Pharmaceutical Industries Ltd (2019-2024)
    Table 85. Sun Pharmaceutical Industries Ltd Recent Developments
    Table 86. TEVA Basic Information List
    Table 87. TEVA Description and Business Overview
    Table 88. TEVA Anti-inflammatory Therapy Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Anti-inflammatory Therapy Business of TEVA (2019-2024)
    Table 90. TEVA Recent Developments
    Table 91. Key Raw Materials Lists
    Table 92. Raw Materials Key Suppliers Lists
    Table 93. Anti-inflammatory Therapy Downstream Customers
    Table 94. Anti-inflammatory Therapy Distributors List
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
    Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Anti-inflammatory Therapy Product Picture
    Figure 2. Global Anti-inflammatory Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Anti-inflammatory Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Anti-inflammatory Therapy Report Years Considered
    Figure 5. Global Anti-inflammatory Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-inflammatory Therapy Revenue in 2023
    Figure 7. Anti-inflammatory Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Corticosteroids Picture
    Figure 9. Anti-inflammatory Biologics Picture
    Figure 10. Non-Steroidal Anti-inflammatory Drugs Picture
    Figure 11. Others Picture
    Figure 12. Global Anti-inflammatory Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Anti-inflammatory Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Respiratory Diseases
    Figure 15. Product Picture of Arthritis
    Figure 16. Product Picture of Gastroenterology
    Figure 17. Product Picture of Dermatology
    Figure 18. Product Picture of Others
    Figure 19. Global Anti-inflammatory Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Anti-inflammatory Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Anti-inflammatory Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Anti-inflammatory Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Anti-inflammatory Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Anti-inflammatory Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Anti-inflammatory Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Anti-inflammatory Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Anti-inflammatory Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Anti-inflammatory Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Anti-inflammatory Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Anti-inflammatory Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Anti-inflammatory Therapy Sales Value (%), (2019-2030)
    Figure 32. United States Anti-inflammatory Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Anti-inflammatory Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Anti-inflammatory Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Anti-inflammatory Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Anti-inflammatory Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Anti-inflammatory Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Anti-inflammatory Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Anti-inflammatory Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Anti-inflammatory Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Anti-inflammatory Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Anti-inflammatory Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Anti-inflammatory Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Anti-inflammatory Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Anti-inflammatory Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Anti-inflammatory Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 53. Anti-inflammatory Therapy Industrial Chain
    Figure 54. Anti-inflammatory Therapy Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS